21. Not just gRASping at flaws: Finding vulnerabilities to develop novel therapies for treating KRAS mutant cancers. Issue 5 (26th March 2014) Authors: Ebi, Hiromichi; Faber, Anthony C.; Engelman, Jeffrey A.; Yano, Seiji Journal: Cancer science Issue: Volume 105:Issue 5(2014:May) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Organ‐specific efficacy of HSP90 inhibitor in multiple‐organ metastasis model of chemorefractory small cell lung cancer. Issue 5 (13th October 2015) Authors: Takeuchi, Shinji; Fukuda, Koji; Arai, Sachiko; Nanjo, Shigeki; Kita, Kenji; Yamada, Tadaaki; Hara, Eiji; Nishihara, Hiroshi; Uehara, Hisanori; Yano, Seiji Journal: International journal of cancer Issue: Volume 138:Issue 5(2016:Mar. 01) Page Start: 1281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Pan‐HER inhibitors overcome lorlatinib resistance caused by NRG1/HER3 activation in ALK‐rearranged lung cancer. Issue 1 (21st September 2022) Authors: Taniguchi, Hirokazu; Akagi, Kazumasa; Dotsu, Yosuke; Yamada, Tadaaki; Ono, Sawana; Imamura, Erika; Gyotoku, Hiroshi; Takemoto, Shinnosuke; Yamaguchi, Hiroyuki; Sen, Triparna; Yano, Seiji; Mukae, Hiroshi Journal: Cancer science Issue: Volume 114:Issue 1(2023) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer. Issue 12 (13th November 2013) Authors: Zhao, Lu; Yasumoto, Kazuo; Kawashima, Atsuhiro; Nakagawa, Takayuki; Takeuchi, Shinji; Yamada, Tadaaki; Matsumoto, Kunio; Yonekura, Kazuhiko; Yoshie, Osamu; Yano, Seiji Journal: Cancer science Issue: Volume 104:Issue 12(2013:Dec.) Page Start: 1640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Patient‐derived xenograft models of non‐small cell lung cancer for evaluating targeted drug sensitivity and resistance. Issue 10 (6th October 2019) Authors: Kita, Kenji; Fukuda, Koji; Takahashi, Hiro; Tanimoto, Azusa; Nishiyama, Akihiro; Arai, Sachiko; Takeuchi, Shinji; Yamashita, Kaname; Ohtsubo, Koshiro; Otani, Sakiko; Yanagimura, Naohiro; Suzuki, Chiaki; Ikeda, Hiroko; Tamura, Masaya; Matsumoto, Isao; Yano, Seiji Journal: Cancer science Issue: Volume 110:Issue 10(2019) Page Start: 3215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Pharmacokinetics of Neoadjuvant Axitinib Influenced the Efficacy in Patients With Advanced Renal Cell Carcinoma. (19th September 2019) Authors: Yamamoto, Yoshiaki; Otori, Toru; Inoue, Ryo; Yano, Seiji; Hirata, Hiroshi; Matsumoto, Hiroaki; Matsuyama, Kenji; Matsuyama, Hideyasu Journal: Journal of clinical pharmacology Issue: Volume 60:Number 2(2020) Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double‐positive lung cancer. Issue 2 (6th January 2020) Authors: Takeuchi, Shinji; Hase, Tetsunari; Shimizu, Shinobu; Ando, Masahiko; Hata, Akito; Murakami, Haruyasu; Kawakami, Takahiro; Nagase, Katsuhiko; Yoshimura, Kenichi; Fujiwara, Tadami; Tanimoto, Azusa; Nishiyama, Akihiro; Arai, Sachiko; Fukuda, Koji; Katakami, Nobuyuki; Takahashi, Toshiaki; Hasegawa, Y... Journal: Cancer science Issue: Volume 111:Issue 2(2020) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L). (26th June 2019) Authors: Kimura, Tatsuo; Kawaguchi, Tomoya; Chiba, Yasutaka; Yoshioka, Hiroshige; Watanabe, Katsuya; Kijima, Takashi; Kogure, Yoshihito; Oguri, Tetsuya; Yoshimura, Naruo; Niwa, Takashi; Kasai, Takashi; Hayashi, Hidetoshi; Ono, Akira; Asai, Kazuhisa; Tanaka, Hiroshi; Yano, Seiji; Yamamoto, Nobuyuki; Nakani... Journal: Japanese journal of clinical oncology Issue: Volume 49:Number 10(2019) Page Start: 947 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation. Issue 4 (12th April 2017) Authors: Takeuchi, Shinji; Fukuda, Koji; Yamada, Tadaaki; Arai, Sachiko; Takagi, Satoshi; Ishii, Genichiro; Ochiai, Atsushi; Iwakiri, Shotaro; Itoi, Kazumi; Uehara, Hisanori; Nishihara, Hiroshi; Fujita, Naoya; Yano, Seiji Journal: Cancer science Issue: Volume 108:Issue 4(2017) Page Start: 696 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. The novel phosphoinositide 3‐kinase–mammalian target of rapamycin inhibitor, BEZ235, circumvents erlotinib resistance of epidermal growth factor receptor mutant lung cancer cells triggered by hepatocyte growth factor. Issue 2 (12th February 2013) Authors: Sano, Takako; Takeuchi, Shinji; Nakagawa, Takayuki; Ishikawa, Daisuke; Nanjo, Shigeki; Yamada, Tadaaki; Nakamura, Takahiro; Matsumoto, Kunio; Yano, Seiji Journal: International journal of cancer Issue: Volume 133:Issue 2(2013:Jul. 15) Page Start: 505 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗